Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria
Journal of Antimicrobial Chemotherapy · 2023
DOI: 10.1093/jac/dkad090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Camille Gonzalez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Team 'Resist', UMR1184 'Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB),' INSERM, Université Paris-Saclay, CEA, LabE…. Hauptthemen laut MEDLINE: Enterobacteriaceae Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Institut National de la Santé et de la Recherche Médicale.
Abstract (Originalsprache)
Background
As carbapenemase-producing Enterobacterales are increasingly reported worldwide, their rapid detection is crucial to reduce their spread and prevent infections and outbreaks. Lateral flow immunoassays (LFIAs) have become major tools for the detection of carbapenemases. However, as for most commercially available assays, only the five main carbapenemases are targeted.
Objectives
Here, we have developed and evaluated an LFIA prototype for the rapid and reliable detection of the increasingly identified GES-type β-lactamases.
Methods
The GES LFIA was validated on 103 well-characterized Gram-negative isolates expressing various β-lactamases grown on Mueller–Hinton (MH) agar, chromogenic, and chromogenic/selective media.
Results
The limit of detection of the assay was 106 cfu per test with bacteria grown on MH agar plates. GES LFIA accurately detected GES-type β-lactamases irrespective of the culture media and the bacterial host. The GES LFIA was not able to distinguish between GES-ESBLs and GES-carbapenemases. Because GES enzymes are still rare, their detection as an ESBL or a carbapenemase remains important, especially because extensive use of carbapenems to treat ESBL infections may select for GES variants capable of hydrolysing carbapenems.
Conclusions
The GES LFIA is efficient, rapid and easy to implement in the routine workflow of a clinical microbiology laboratory for the confirmation of GES-type β-lactamases. Combining it with immunochromatographic assays targeting the five main carbapenemases (KPC, NDM, VIM, IMP and OXA-48) would improve the overall sensitivity for the most frequently encountered carbapenemases and ESBLs, especially in non-fermenters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Team 'Resist', UMR1184 'Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB),' INSERM, Université Paris-Saclay, CEA, LabEx LERMIT, Faculty of Medicine, Le Kremlin-Bicêtre, France.
- Bacteriology-Hygiene Unit, Assistance Publique-Hôpitaux de Paris, AP-HP Paris-Saclay, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
- Département Médicaments et Technologies pour la Santé, Université Paris-Saclay, CEA, INRAE, 91191 Gif-sur-Yvette, France.
- Research and Development Department, NG-Biotech, Guipry, France.
- Associated French National Reference Center for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae, Le Kremlin-Bicêtre, France.
ORCID-Profile: Thierry Naas
Förderung
- Assistance Publique-Hôpitaux de Paris
- Université Paris-Saclay
- Institut National de la Santé et de la Recherche Médicale
- French National Research Agency
Zitieren
APA
Gonzalez, C., Volland, H., Oueslati, S., Niol, L., Legrand, C., Francius, L., Chalin, A., Vogel, A., Simon, S., & Naas, T. (2023). Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad090
Vancouver
Gonzalez C, Volland H, Oueslati S, Niol L, Legrand C, Francius L, et al. Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad090
BibTeX
@article{Gonzalez2023,
author = {Gonzalez, Camille and Volland, Hervé and Oueslati, Saoussen and Niol, Léa and Legrand, Camille and Francius, Laura and Chalin, Arnaud and Vogel, Anaïs and Simon, Stéphanie and Naas, Thierry},
title = {Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
doi = {10.1093/jac/dkad090}
}
EUVIMED